Snowdome supports epigenetic BET inhibitors clinical trial

As today is International Clinical Trials Day (commemorating 20 May 1747, the day on which James Lind started his famous trial comparing treatments for scurvy), Snowdome is proud to share the following links to articles that appeared in the media today. The trial in the spotlight of all articles is supported by Snowdome funding. Consultant haematologists … Continued

recently approved research projects

Over the last 9 months, Snowdome’s funding efforts have been concentrated on directing just over $1,000,000 into epigenetic treatments for Australians with blood cancers. Snowdome has worked with several passionate donors to invest over $750,000 and has successfully secured $311,000 in matched funding through the Victorian Cancer Agency. A wonderful model of ‘government & philanthropy’ … Continued